Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-10
2007-07-10
Gaeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S218000, C514S253090, C514S254050, C514S305000, C514S326000, C514S318000, C540S575000, C544S364000, C544S370000, C546S133000, C546S194000, C546S210000, C546S274100, C548S251000, C548S255000, C548S263200, C548S311100, C548S316400
Reexamination Certificate
active
11042713
ABSTRACT:
The invention relates to substituted N-cyclohexylheterocycles and to the physiologically tolerated salts and physiologically functional derivatives thereof, to processes for their preparation and to their use as medicaments.Compounds of the formula I,in which the radicals have the stated meanings, and the physiologically tolerated salts thereof, and process for their preparation are described. The compounds bring about for example a weight reduction in mammals and are suitable for example for the prevention and treatment of obesity and diabetes.
REFERENCES:
patent: 5190923 (1993-03-01), Vincent et al.
patent: 5276049 (1994-01-01), Himmelsbach et al.
patent: 5478942 (1995-12-01), Himmelsbach et al.
patent: 5650424 (1997-07-01), Himmelsbach et al.
patent: 5681841 (1997-10-01), Himmelsbach et al.
patent: 5852192 (1998-12-01), Himmelsbach et al.
patent: 5880284 (1999-03-01), Himmelsbach et al.
patent: 6221633 (2001-04-01), Ertl et al.
patent: 6245744 (2001-06-01), Frick et al.
patent: 6277831 (2001-08-01), Frick et al.
patent: 6342512 (2002-01-01), Kirsch et al.
patent: 6500804 (2002-12-01), Demuth et al.
patent: 6890905 (2005-05-01), Demuth et al.
patent: WO 94/18183 (1994-08-01), None
patent: WO 94/18184 (1994-08-01), None
patent: WO 97/26265 (1997-07-01), None
patent: WO 98/08871 (1998-03-01), None
patent: WO 98/19998 (1998-05-01), None
patent: WO 99/03861 (1999-01-01), None
patent: WO 99/15525 (1999-04-01), None
patent: WO 99/61431 (1999-12-01), None
patent: WO 99/67278 (1999-12-01), None
patent: WO 99/67279 (1999-12-01), None
patent: WO 00/40569 (2000-07-01), None
patent: WO 00/63208 (2000-10-01), None
patent: WO 00/66585 (2000-11-01), None
patent: WO 00/71549 (2000-11-01), None
patent: WO 00/78312 (2000-12-01), None
patent: WO 01/04146 (2001-01-01), None
patent: WO 01/09111 (2001-02-01), None
patent: WO 01/21577 (2001-03-01), None
patent: WO 01/83451 (2001-11-01), None
patent: WO 01/85695 (2001-11-01), None
patent: WO 01/91752 (2001-12-01), None
patent: WO 01/94300 (2001-12-01), None
patent: WO 02/002744 (2002-01-01), None
patent: WO 02/06245 (2002-01-01), None
patent: WO 02/10146 (2002-02-01), None
patent: WO 02/38541 (2002-05-01), None
patent: WO 02/50027 (2002-06-01), None
patent: WO 02/057233 (2002-07-01), None
patent: WO 02/089729 (2002-11-01), None
patent: WO 02/096864 (2002-12-01), None
patent: WO 03/035624 (2003-05-01), None
patent: WO 03/040174 (2003-05-01), None
patent: WO 03/045313 (2003-06-01), None
patent: WO 03/057220 (2003-07-01), None
patent: WO 03/084922 (2003-10-01), None
patent: WO 03/084923 (2003-10-01), None
patent: WO 03/087044 (2003-10-01), None
patent: WO 03/097047 (2003-11-01), None
patent: WO 03/104188 (2003-12-01), None
patent: WO 2004/011438 (2004-02-01), None
Asakawa, A., et. al., Cocaine-Amphetamine-Regulated Transcript Influences Energy Metabolism, Anxiety And Gastric Emptying in Mice, Hormone And Metabolic Research (2002, pp. 554-558, vol. 33, No. 9).
Borowsky, B., et. al., Antidepressant, Anxiolytic and Anorectic Effects of a Melanin-Concentrating Hormone-1 Receptor Antagonist, Nature Medicine (2002, pp. 825-830, vol. 8, No. 8).
Lee, D.W., et. al., Leptin Agonists As A Potential Approach To The Treatment Of Obesity, Drugs Of The Future (2001, pp. 873-881, vol. 26, Issue 9).
Qu, D., et. al., A Role For Melanin-Concentrating Hormone In The Central Regulation Of Feeding Behaviour, Nature (1996, pp. 243-247, vol. 380).
Zunft, H.J., et. al., Carob Pulp Preparation for Treament of Hypercholesterolemia, Advances in Natural Therapy (2001, pp. 230-236, vol. 18, No. 5).
Hervieu, G., et. al., Melanin-concentrating hormone functions in the nervous system: food intake and stress, Expert Opin (2003, pp. 495-511, vol. 7, No. 4).
Okada, H., et. al., Synthesis And Antitumor Activities Of Prodrugs Of Benzoylphenylureas, Chem. Pharm. Bull (1994, 57-61, vol. 42, No. 1).
Kawafuchi, H., et. al., Novel Access to Cyclohexane-1,4-Diones and 1,4-Hydroquinones via Radical 1,2-Acyl Rearrangement on 2-(Halomethyl) Cyclopentane-1,3-Diones Using Cobaloxime-Mediated Electroreduction or Tributyltin Hydride, Tetrahedron Letters (2002, pp. 2051-2054, vol. 43).
Beauhaire, J., et. al., Indentification And Synthesis Of Sordidin, a Male Pheromone Emitted by Cosmopolites Sordidus, Tetrahedron Letter (1995, pp. 1043-1046, vol. 36, No. &).
Pereira-Da-Silva, M., et. al., Hypothalamic Melanin-Concentrating Hormone Is Induced by Cold Exposure and Participates in the Control of Energy Expenditure in Rats, Endocrinology (2003, pp. 4831-4840, vol. 144).
Nakamura, M., et. al., Enantioselective Synthesis of alpha-Substituted Ketones by Asymmetric Addition of Chiral Zinc Enamides to 1-Alkenes, J. Am. Chem. Soc. (2003, pp. 6362-6363, vol. 125).
Shimada, M., et. al., Mice Lacking Melanin-Concentrating Hormone Are Hypophagic And Lean, Nature (1998, pp. 670-674, vol. 396).
Chen, Y., et. al., Targeted Disruption of the Melanin-Concentrating Hormone Receptor-1 Results in Hyperphagia and Resistance to Diet-Induced Obesity, Endocrinology (2002, pp. 2469-2477, vol. 143).
Boehme Thomas
Gossel Matthias
Schwink Lothar
Stengelin Siegfried
Gaeed Kamal A.
Kurys Barbara E.
Nolan Jason M.
Sanofi-Aventis Deutschland GmbH
LandOfFree
Substituted N-cycloexylimidazolinones, process for their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted N-cycloexylimidazolinones, process for their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted N-cycloexylimidazolinones, process for their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3722650